title: C-reactive protein and cholesterol are equally strong predictors of cardiovascular risk and both are important for quality clinical care.
authors: Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital and Harvard Medical School, 900 Commonwealth Ave East, Boston, MA 02215, USA. pridker@partners.org
authors: Paul M
authors: PM
authors: Ridker
authors: John J P
authors: JJ
authors: Kastelein
authors: Jacques
authors: J
authors: Genest
authors: Wolfgang
authors: W
authors: Koenig
mesh_terms: D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012015:Reference Standards; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D015415:Biomarkers; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002097:C-Reactive Protein; D002784:Cholesterol